Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose-Reference-Cited by-同舟云学术

Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose

Published:2009-12 Issue:6 Volume:19 Page:637-642
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Hashiramoto Akira,Shiozawa Kazuko,Tanaka Yasushi,Yamane Takashi,Murata Miki,Tanaka Chihiro,Terashima Yasuhiro,Koyama Kozo,Nakagawa Natsuko,Abe Shuji,Yoshihara Rhosuke,Saegusa Yasuhiro,Tsumiyama Ken,Komai Koichiro,Sakai Yoshitada,Shiozawa Shunichi

Publisher

Oxford University Press (OUP)

Subject

Rheumatology

Link

http://www.tandfonline.com/doi/pdf/10.3109/s10165-009-0205-x

Reference18 articles.

1. New Drugs for Rheumatoid Arthritis

2. Rational Use of New and Existing Disease-Modifying Agents in Rheumatoid Arthritis

3. Methotrexate therapy in rheumatoid arthritis: 15 years experience

4. Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis

5. The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: a postmarketing surveillance report;Modern Rheumatology;2019-01-03

2. RETRACTED ARTICLE: Safety and effectiveness of high-dose methotrexate (over 8 mg/week) in 2838 Japanese patients with rheumatoid arthritis: A postmarketing surveillance report;Modern Rheumatology;2017-04-11

3. Rheumatoid Factor Is Associated With the Distribution of Hand Joint Destruction in Rheumatoid Arthritis;Arthritis & Rheumatology;2015-11-25

4. Tumor Necrosis Factor and Transforming Growth Factor β Regulate Clock Genes by Controlling the Expression of the Cold Inducible RNA-binding Protein (CIRBP);Journal of Biological Chemistry;2014-01

5. Studies of the efficacy and safety of methotrexate at dosages over 8 mg/week using the IORRA cohort database;Modern Rheumatology;2011-12